Intellia Therapeutics (NTLA) Stock Price & Financial Analysis
Intellia Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Intellia Therapeutics
What is the current stock price for NTLA?
As of the latest trading session, NTLA stock trades at $11.94. The 52-week range is $6.83–$28.25, with a day range of $11.84–$12.42.
What is the P/E ratio for NTLA?
The P/E ratio (Price-to-Earnings) for NTLA is shown in the Key Statistics section. This valuation metric helps compare Intellia Therapeutics, Inc. to industry peers.
Does NTLA pay dividends?
Intellia Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NTLA?
Based on 11 analysts, the consensus for NTLA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of NTLA?
Intellia Therapeutics's market capitalization is $1.29B, classifying it as a small-cap company..